Novartis CEO Vas Narasimhan (L) and Pfizer CEO Albert Bourla (Akio Kon/Bloomberg via Getty Images; Hannes P Albert/picture-alliance/dpa/AP Images)
February 23, 2024 02:24 PM ESTUpdated 02:40 PM
Pharma
Marketing

Pfiz­er and No­var­tis chiefs lead phar­ma's CEO in­flu­encers on so­cial me­dia, analy­sis finds

Beth Snyder Bulik

Senior Editor

When it comes to phar­ma CEOs as so­cial in­flu­encers, Pfiz­er’s Al­bert Bourla is a per­fect 10 com­pared to his peers.

No­var­tis CEO Vas Narasimhan is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times